iShares Genomics Immunology and Healthcare ETF Rating $24.64 +0.18 (+0.74%) Closing price 10/3/2025 04:10 PM EasternExtended Trading$24.66 +0.02 (+0.06%) As of 10/3/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.58Holdings in IDNA have an aggregate rating of Moderate Buy based on 250 analyst ratings issued in the past year covering 17 companies (54.9% of the portfolio).IDNA Aggregate Price Target$24.64High Prediction$24.64Average Prediction$24.64Low Prediction$24.64Holdings in IDNA have an aggregate price target of $24.64 and a range of $24.64 to $24.64 covering 17 companies (54.9% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.76%INCYIncyte$86.85+0.7%4.5144 of 5 stars2.28$83.64 -3.7%18Analyst Upgrade4.62%REGNRegeneron Pharmaceuticals$600.004.7523 of 5 stars2.79$817.67 36.3%29Positive NewsAnalyst Revision4.47%ACLXArcellx$85.07+3.4%2.2146 of 5 stars3.00$114.31 34.4%16Insider TradeHigh Trading Volume4.19%RVMDRevolution Medicines$46.71+2.2%4.2883 of 5 stars2.93$74.64 59.8%153.93%MRKMerck & Co., Inc.$89.25-0.3%4.9964 of 5 stars2.32$106.41 19.2%22Positive NewsOptions Volume3.65%CELCCelcuity$50.51+2.2%2.1166 of 5 stars2.67$56.50 11.9%6Analyst Forecast3.58%EXELExelixis$40.09-3.0%4.8188 of 5 stars2.63$44.42 10.8%24Analyst Upgrade3.53%MRNAModerna$28.49+0.4%4.1637 of 5 stars2.00$41.81 46.8%23Options Volume3.38%BNTXBioNTech$105.49+0.9%2.683 of 5 stars2.67$134.56 27.6%15Positive News3.37%TWSTTwist Bioscience$31.07+1.3%3.6995 of 5 stars2.55$48.90 57.4%11Analyst Forecast2.74%BCRXBioCryst Pharmaceuticals$7.15-2.5%4.0341 of 5 stars2.64$16.30 128.0%11News CoverageAnalyst Forecast2.71%NVAXNovavax$9.46-0.9%4.315 of 5 stars2.00$14.29 51.0%9Options Volume2.60%JANXJanux Therapeutics$24.00+3.0%2.2312 of 5 stars2.94$78.31 226.3%172.27%ABCLAbCellera Biologics$5.90-1.3%3.1935 of 5 stars2.71$8.00 35.6%7News CoverageGap Up1.71%GERNGeron$1.35-2.2%2.9257 of 5 stars2.13$3.79 180.4%81.71%RCUSArcus Biosciences$13.35-0.2%1.7655 of 5 stars2.50$21.14 58.4%81.63%IMNMImmunome$12.38+7.9%1.7789 of 5 stars2.82$23.20 87.4%11 This page (NYSEARCA:IDNA) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDNA Stock Alerts